Skin Rejuvenation Devices Market Size, Share, and Trends 2025 to 2034

Skin Rejuvenation Devices Market (By Product / Device Type: Laser & IPL Platforms, Radiofrequency Devices, Microneedling Devices (non-RF), LED / Light Therapy Devices; By Technology: Ablative fractional, Microneedle RF, IPL broad-band, LED photobiomodulation; By Indication / Clinical Use: Wrinkle Reduction & Skin Tightening, Pigmentation & Melasma Management, Scar & Acne-scar Remodeling, Texture / Pore Reduction & Skin Quality, Vascular Lesions & Rosacea, Overall Rejuvenation & Combination Protocols; By End User / Channel: Dermatology & Plastic Surgery Clinics (Dominant), Medspas & Cosmetic Chains, Hospitals & Ambulatory Surgery Centers, At-home / Consumer FDA-cleared devices; By Revenue Model / Component: Capital equipment sales, Consumables, tips & disposable cartridges, Service, training & software (SaaS, AI diagnostics, imaging add-ons))

Last Updated : September 2025  |  Report Code : 6864  |  Category : Healthcare  |  Format : PDF / PPT / Excel

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology  

 2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Skin Rejuvenation Devices Market 

5.1. COVID-19 Landscape: Skin Rejuvenation Devices Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Skin Rejuvenation Devices Market, By Product / Device Type

8.1. Skin Rejuvenation Devices Market Revenue and Volume, by Product / Device Type

8.1.1. Laser & IPL Platforms

8.1.1.1. Market Revenue and Volume Forecast  

8.1.2. Radiofrequency Devices

8.1.2.1. Market Revenue and Volume Forecast  

8.1.3. Microneedling Devices (non-RF)

8.1.3.1. Market Revenue and Volume Forecast  

8.1.4. Combination / Hybrid Platforms (Laser + RF, RF + Ultrasound, Laser + PRP integration)

8.1.4.1. Market Revenue and Volume Forecast  

8.1.5. High-Intensity Focused Ultrasound (HIFU) & Ultrasound-assisted

8.1.5.1. Market Revenue and Volume Forecast  

8.1.6. LED / Light Therapy Devices

8.1.6.1. Market Revenue and Volume Forecast  

8.1.7. Cryotherapy / CoolSculpting-adjunct & Other Modalities

8.1.7.1. Market Revenue and Volume Forecast  

Chapter 9. Global Skin Rejuvenation Devices Market, By Technology

9.1. Skin Rejuvenation Devices Market Revenue and Volume, by Technology

9.1.1. Ablative fractional

9.1.1.1. Market Revenue and Volume Forecast  

9.1.2. Picosecond & Q-switched (Fastest Growing for pigmentation & tattoo retreatment).

9.1.2.1. Market Revenue and Volume Forecast  

9.1.3. Microneedle RF

9.1.3.1. Market Revenue and Volume Forecast  

9.1.4. IPL broad-band

9.1.4.1. Market Revenue and Volume Forecast

9.1.5. LED photobiomodulation

9.1.5.1. Market Revenue and Volume Forecast 

Chapter 10. Global Skin Rejuvenation Devices Market, By Indication / Clinical Use

10.1. Skin Rejuvenation Devices Market Revenue and Volume, by Indication / Clinical Use

10.1.1. Wrinkle Reduction & Skin Tightening

10.1.1.1. Market Revenue and Volume Forecast  

10.1.2. Pigmentation & Melasma Management

10.1.2.1. Market Revenue and Volume Forecast  

10.1.3. Scar & Acne-scar Remodeling

10.1.3.1. Market Revenue and Volume Forecast  

10.1.4. Texture / Pore Reduction & Skin Quality

10.1.4.1. Market Revenue and Volume Forecast  

10.1.5. Vascular Lesions & Rosacea

10.1.5.1. Market Revenue and Volume Forecast

10.1.6. Overall Rejuvenation & Combination Protocols

10.1.6.1. Market Revenue and Volume Forecast    

Chapter 11. Global Skin Rejuvenation Devices Market, By End User / Channel

11.1. Skin Rejuvenation Devices Market Revenue and Volume, by End User / Channel

11.1.1. Dermatology & Plastic Surgery Clinics (Dominant)

11.1.1.1. Market Revenue and Volume Forecast  

11.1.2. Medspas & Cosmetic Chains

11.1.2.1. Market Revenue and Volume Forecast  

11.1.3. Hospitals & Ambulatory Surgery Centers

11.1.3.1. Market Revenue and Volume Forecast  

11.1.4. At-home / Consumer FDA-cleared devices

11.1.4.1. Market Revenue and Volume Forecast  

Chapter 12. Global Skin Rejuvenation Devices Market, By Revenue Model / Component

12.1. Skin Rejuvenation Devices Market Revenue and Volume, by Revenue Model / Component

12.1.1. Capital equipment sales

12.1.1.1. Market Revenue and Volume Forecast  

12.1.2. Consumables, tips & disposable cartridges

12.1.2.1. Market Revenue and Volume Forecast  

12.1.3. Service, training & software (SaaS, AI diagnostics, imaging add-ons)

12.1.3.1. Market Revenue and Volume Forecast  

Chapter 14. Global Skin Rejuvenation Devices Market, Regional Estimates and Trend Forecast

14.1. North America

14.1.1. Market Revenue and Volume Forecast, by Product / Device Type  

14.1.2. Market Revenue and Volume Forecast, by Technology  

14.1.3. Market Revenue and Volume Forecast, by Indication / Clinical Use  

14.1.4. Market Revenue and Volume Forecast, by End User / Channel  

14.1.5. Market Revenue and Volume Forecast, by Revenue Model / Component  

14.1.6. Market Revenue and Volume Forecast, by June  

14.1.7. U.S.

14.1.7.1. Market Revenue and Volume Forecast, by Product / Device Type  

14.1.7.2. Market Revenue and Volume Forecast, by Technology  

14.1.7.3. Market Revenue and Volume Forecast, by Indication / Clinical Use  

14.1.7.4. Market Revenue and Volume Forecast, by End User / Channel  

14.1.8. Market Revenue and Volume Forecast, by Revenue Model / Component  

14.1.8.1. Market Revenue and Volume Forecast, by June   

14.1.9. Rest of North America

14.1.9.1. Market Revenue and Volume Forecast, by Product / Device Type  

14.1.9.2. Market Revenue and Volume Forecast, by Technology  

14.1.9.3. Market Revenue and Volume Forecast, by Indication / Clinical Use  

14.1.9.4. Market Revenue and Volume Forecast, by End User / Channel  

14.1.10. Market Revenue and Volume Forecast, by Revenue Model / Component  

14.1.11. Market Revenue and Volume Forecast, by June  

14.1.11.1.

14.2. Europe

14.2.1. Market Revenue and Volume Forecast, by Product / Device Type  

14.2.2. Market Revenue and Volume Forecast, by Technology  

14.2.3. Market Revenue and Volume Forecast, by Indication / Clinical Use  

14.2.4. Market Revenue and Volume Forecast, by End User / Channel   

14.2.5. Market Revenue and Volume Forecast, by Revenue Model / Component  

14.2.6. Market Revenue and Volume Forecast, by June  

14.2.7.

14.2.8. UK

14.2.8.1. Market Revenue and Volume Forecast, by Product / Device Type  

14.2.8.2. Market Revenue and Volume Forecast, by Technology  

14.2.8.3. Market Revenue and Volume Forecast, by Indication / Clinical Use  

14.2.9. Market Revenue and Volume Forecast, by End User / Channel   

14.2.10. Market Revenue and Volume Forecast, by Revenue Model / Component  

14.2.10.1. Market Revenue and Volume Forecast, by June   

14.2.11. Germany

14.2.11.1. Market Revenue and Volume Forecast, by Product / Device Type  

14.2.11.2. Market Revenue and Volume Forecast, by Technology  

14.2.11.3. Market Revenue and Volume Forecast, by Indication / Clinical Use  

14.2.12. Market Revenue and Volume Forecast, by End User / Channel  

14.2.13. Market Revenue and Volume Forecast, by Revenue Model / Component  

14.2.14. Market Revenue and Volume Forecast, by June  

14.2.14.1.

14.2.15. France

14.2.15.1. Market Revenue and Volume Forecast, by Product / Device Type  

14.2.15.2. Market Revenue and Volume Forecast, by Technology  

14.2.15.3. Market Revenue and Volume Forecast, by Indication / Clinical Use  

14.2.15.4. Market Revenue and Volume Forecast, by End User / Channel  

14.2.16. Market Revenue and Volume Forecast, by Revenue Model / Component  

14.2.16.1. Market Revenue and Volume Forecast, by June  

14.2.17. Rest of Europe

14.2.17.1. Market Revenue and Volume Forecast, by Product / Device Type  

14.2.17.2. Market Revenue and Volume Forecast, by Technology  

14.2.17.3. Market Revenue and Volume Forecast, by Indication / Clinical Use  

14.2.17.4. Market Revenue and Volume Forecast, by End User / Channel  

14.2.18. Market Revenue and Volume Forecast, by Revenue Model / Component  

14.2.18.1. Market Revenue and Volume Forecast, by June  

14.3. APAC

14.3.1. Market Revenue and Volume Forecast, by Product / Device Type  

14.3.2. Market Revenue and Volume Forecast, by Technology  

14.3.3. Market Revenue and Volume Forecast, by Indication / Clinical Use  

14.3.4. Market Revenue and Volume Forecast, by End User / Channel  

14.3.5. Market Revenue and Volume Forecast, by Revenue Model / Component  

14.3.6. Market Revenue and Volume Forecast, by June  

14.3.7. India

14.3.7.1. Market Revenue and Volume Forecast, by Product / Device Type  

14.3.7.2. Market Revenue and Volume Forecast, by Technology  

14.3.7.3. Market Revenue and Volume Forecast, by Indication / Clinical Use  

14.3.7.4. Market Revenue and Volume Forecast, by End User / Channel  

14.3.8. Market Revenue and Volume Forecast, by Revenue Model / Component  

14.3.9. Market Revenue and Volume Forecast, by June  

14.3.10. China

14.3.10.1. Market Revenue and Volume Forecast, by Product / Device Type  

14.3.10.2. Market Revenue and Volume Forecast, by Technology  

14.3.10.3. Market Revenue and Volume Forecast, by Indication / Clinical Use  

14.3.10.4. Market Revenue and Volume Forecast, by End User / Channel  

14.3.11. Market Revenue and Volume Forecast, by Revenue Model / Component  

14.3.11.1. Market Revenue and Volume Forecast, by June  

14.3.12. Japan

14.3.12.1. Market Revenue and Volume Forecast, by Product / Device Type  

14.3.12.2. Market Revenue and Volume Forecast, by Technology  

14.3.12.3. Market Revenue and Volume Forecast, by Indication / Clinical Use  

14.3.12.4. Market Revenue and Volume Forecast, by End User / Channel  

14.3.12.5. Market Revenue and Volume Forecast, by Revenue Model / Component  

14.3.12.6. Market Revenue and Volume Forecast, by June  

14.3.13. Rest of APAC

14.3.13.1. Market Revenue and Volume Forecast, by Product / Device Type  

14.3.13.2. Market Revenue and Volume Forecast, by Technology  

14.3.13.3. Market Revenue and Volume Forecast, by Indication / Clinical Use  

14.3.13.4. Market Revenue and Volume Forecast, by End User / Channel  

14.3.13.5. Market Revenue and Volume Forecast, by Revenue Model / Component  

14.3.13.6. Market Revenue and Volume Forecast, by June  

14.4. MEA

14.4.1. Market Revenue and Volume Forecast, by Product / Device Type  

14.4.2. Market Revenue and Volume Forecast, by Technology  

14.4.3. Market Revenue and Volume Forecast, by Indication / Clinical Use  

14.4.4. Market Revenue and Volume Forecast, by End User / Channel  

14.4.5. Market Revenue and Volume Forecast, by Revenue Model / Component  

14.4.6. Market Revenue and Volume Forecast, by June  

14.4.7. GCC

14.4.7.1. Market Revenue and Volume Forecast, by Product / Device Type  

14.4.7.2. Market Revenue and Volume Forecast, by Technology  

14.4.7.3. Market Revenue and Volume Forecast, by Indication / Clinical Use  

14.4.7.4. Market Revenue and Volume Forecast, by End User / Channel  

14.4.8. Market Revenue and Volume Forecast, by Revenue Model / Component  

14.4.9. Market Revenue and Volume Forecast, by June  

14.4.10. North Africa

14.4.10.1. Market Revenue and Volume Forecast, by Product / Device Type  

14.4.10.2. Market Revenue and Volume Forecast, by Technology  

14.4.10.3. Market Revenue and Volume Forecast, by Indication / Clinical Use  

14.4.10.4. Market Revenue and Volume Forecast, by End User / Channel  

14.4.11. Market Revenue and Volume Forecast, by Revenue Model / Component  

14.4.12. Market Revenue and Volume Forecast, by June  

14.4.13. South Africa

14.4.13.1. Market Revenue and Volume Forecast, by Product / Device Type  

14.4.13.2. Market Revenue and Volume Forecast, by Technology  

14.4.13.3. Market Revenue and Volume Forecast, by Indication / Clinical Use  

14.4.13.4. Market Revenue and Volume Forecast, by End User / Channel  

14.4.13.5. Market Revenue and Volume Forecast, by Revenue Model / Component  

14.4.13.6. Market Revenue and Volume Forecast, by June  

14.4.14. Rest of MEA

14.4.14.1. Market Revenue and Volume Forecast, by Product / Device Type  

14.4.14.2. Market Revenue and Volume Forecast, by Technology  

14.4.14.3. Market Revenue and Volume Forecast, by Indication / Clinical Use  

14.4.14.4. Market Revenue and Volume Forecast, by End User / Channel  

14.4.14.5. Market Revenue and Volume Forecast, by Revenue Model / Component  

14.4.14.6. Market Revenue and Volume Forecast, by June  

14.5. Latin America

14.5.1. Market Revenue and Volume Forecast, by Product / Device Type  

14.5.2. Market Revenue and Volume Forecast, by Technology  

14.5.3. Market Revenue and Volume Forecast, by Indication / Clinical Use  

14.5.4. Market Revenue and Volume Forecast, by End User / Channel  

14.5.5. Market Revenue and Volume Forecast, by Revenue Model / Component  

14.5.6. Market Revenue and Volume Forecast, by June  

14.5.7. Brazil

14.5.7.1. Market Revenue and Volume Forecast, by Product / Device Type  

14.5.7.2. Market Revenue and Volume Forecast, by Technology  

14.5.7.3. Market Revenue and Volume Forecast, by Indication / Clinical Use  

14.5.7.4. Market Revenue and Volume Forecast, by End User / Channel  

14.5.8. Market Revenue and Volume Forecast, by Revenue Model / Component  

14.5.8.1. Market Revenue and Volume Forecast, by June  

14.5.9. Rest of LATAM

14.5.9.1. Market Revenue and Volume Forecast, by Product / Device Type  

14.5.9.2. Market Revenue and Volume Forecast, by Technology  

14.5.9.3. Market Revenue and Volume Forecast, by Indication / Clinical Use  

14.5.9.4. Market Revenue and Volume Forecast, by End User / Channel  

14.5.9.5. Market Revenue and Volume Forecast, by Revenue Model / Component  

14.5.9.6. Market Revenue and Volume Forecast, by June  

Chapter 15. Company Profiles

15.1. Lumenis

15.1.1. Company Overview

15.1.2. Product Offerings

15.1.3. Financial Performance

15.1.4. Recent Initiatives

15.2. Candela / Syneron Candela

15.2.1. Company Overview

15.2.2. Product Offerings

15.2.3. Financial Performance

15.2.4. Recent Initiatives

15.3. Cutera

15.3.1. Company Overview

15.3.2. Product Offerings

15.3.3. Financial Performance

15.3.4. Recent Initiatives

15.4. Alma Lasers

15.4.1. Company Overview

15.4.2. Product Offerings

15.4.3. Financial Performance

15.4.4. Recent Initiatives

15.5. Cynosure (Hologic)

15.5.1. Company Overview

15.5.2. Product Offerings

15.5.3. Financial Performance

15.5.4. Recent Initiatives

15.6. Sciton

15.6.1. Company Overview

15.6.2. Product Offerings

15.6.3. Financial Performance

15.6.4. Recent Initiatives

15.7. Fotona

15.7.1. Company Overview

15.7.2. Product Offerings

15.7.3. Financial Performance

15.7.4. Recent Initiatives

15.8. Lutronic

15.8.1. Company Overview

15.8.2. Product Offerings

15.8.3. Financial Performance

15.8.4. Recent Initiatives

15.9. InMode

15.9.1. Company Overview

15.9.2. Product Offerings

15.9.3. Financial Performance

15.9.4. Recent Initiatives

15.10. BTL Aesthetics

15.10.1. Company Overview

15.10.2. Product Offerings

15.10.3. Financial Performance

15.10.4. Recent Initiatives

Chapter 16. Research Methodology

16.1. Primary Research

16.2. Secondary Research

16.3. Assumptions

Chapter 17. Appendix

17.1. About Us

17.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global skin rejuvenation devices market size is expected to grow from USD 2.54 billion in 2024 to USD 5.99 billion by 2034.

The skin rejuvenation devices market is anticipated to grow at a CAGR of 8.95% between 2025 and 2034.

The major players operating in the skin rejuvenation devices market are Lumenis, Candela / Syneron Candela, Cutera, Alma Lasers, Cynosure (Hologic), Sciton, Fotona, Lutronic, InMode, BTL Aesthetics, Venus Concept, Jeisys Medical, Solta Medical (Thermage), Merz Aesthetics (device partnerships), Classys (HIFU + laser hybrids), Hironic / WONTECH (APAC device vendors), Endymed Medical (RF fractional tech), Kerastem / small specialist OEMs (picosecond/niche lasers), Omnilux / Photomed (clinical LED), Numerous regional manufacturers & private-label OEMs serving medspa channel, and others.

The driving factors of the skin rejuvenation devices market are the growing preference for non-invasive and minimally invasive treatments.

North America region will lead the global skin rejuvenation devices market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client